This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Inc., Synthekine, Synthekine, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Mahalakshmi Ramadass: Innovator in IL10 Receptor Therapeutics
Introduction
Mahalakshmi Ramadass is an accomplished inventor based in Menlo Park, California. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic molecules.
Latest Patents
Mahalakshmi holds a patent for "IL10 receptor binding molecules and methods of use." This innovative patent includes IL10R binding molecules that specifically bind to IL10Ra and IL10Rb, comprising an IL10Rb sdAb and an IL10Rb VHH antibody. This invention has the potential to advance therapeutic approaches for diseases associated with the IL10 receptor.
Career Highlights
Currently, Mahalakshmi is associated with Synthekine, Inc., where he continues to push the boundaries of biotherapeutics. His work is fundamental to the ongoing research and development at the company, positioning it at the forefront of innovations in immune modulation.
Collaborations
Throughout his career, Mahalakshmi has collaborated with notable professionals in his field, including Robert Kastelein and Deepti Rokkam. These partnerships enhance the quality of research and foster innovation in the development of new therapies.
Conclusion
Mahalakshmi Ramadass's invention of IL10 receptor binding molecules highlights his commitment to advancing medical science. As he continues to work at Synthekine, Inc., his contributions will undoubtedly lead to new insights and breakthroughs in the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile